Skip to content

Frontlight Research

Trial site

Örebro

Örebro, SwedenNot linked to an institution yet

2running trials
2closed trials
0trials confirmed by the site in the last 60 days
–languages not stated

The site has not confirmed any trial yet.

Running trials

Active, not recruiting
A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC
NCT02489318· PHASE3· Source
Active, not recruiting
A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer
NCT01946204· PHASE3· Source

Researchers

No researcher is linked here yet.

Closed trials

Completed
Study Comparing Daratumumab, Lenalidomide, and Dexamethasone With Lenalidomide and Dexamethasone in Participants With Previously Untreated Multiple Myeloma
NCT02252172· PHASE3· Source
Completed
Addition of Daratumumab to Combination of Bortezomib and Dexamethasone in Participants With Relapsed or Refractory Multiple Myeloma
NCT02136134· PHASE3· Source

Site data: CTGOVUpdated 5 Nov 2026

Report an error